Correlation Between Mallampati Score and Obstructive Sleep Apnea Risk
Mallampati Score as a Risk Factor for OSA
- The American Academy of Sleep Medicine includes the Modified Mallampati score in comprehensive OSA risk assessment protocols, with scores of 3 or 4 considered significant risk factors for OSA 1, 2
- Physical examination for OSA risk should include evaluation of the Modified Mallampati score, along with other airway features such as retrognathia, lateral peritonsillar narrowing, and tonsillar hypertrophy 2
- A high Mallampati score (3 or 4) is specifically listed as a secondary criterion for OSA risk assessment in commercial motor vehicle operators 1
Clinical Applications
- The Mallampati score is incorporated into the MACOCHA score, a validated predictive tool for difficult intubation in intensive care settings, where OSA is a significant risk factor 3
- The American Academy of Sleep Medicine recommends that Mallampati score should be assessed during routine health maintenance evaluations as part of OSA screening, especially in patients with other risk factors such as obesity, hypertension, or diabetes 2
- When evaluating OSA risk in commercial drivers, a Mallampati classification of 3 or 4 is considered a significant secondary criterion that warrants further evaluation 1
Clinical Pearls and Pitfalls
- The American Academy of Sleep Medicine suggests that when using Mallampati for OSA risk assessment, combine it with other clinical parameters (BMI, neck circumference, symptoms) for better predictive value 1, 2
Practical Application in Screening Protocols
- For primary care screening, the American Academy of Sleep Medicine recommends including Mallampati assessment alongside evaluation for snoring, witnessed apneas, daytime sleepiness, obesity, retrognathia, and hypertension 2
- In high-risk occupations like commercial driving, the American Academy of Sleep Medicine recommends using Mallampati score as a secondary criterion after evaluating primary risk factors like BMI ≥ 33 kg/m², hypertension requiring multiple medications, and type 2 diabetes 1